Wells Fargo’s Prelude Therapeutics PRLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240 | Sell |
297
-7,615
| -96% | -$6.15K | ﹤0.01% | 5968 |
|
|
2025
Q1 | $6.08K | Buy |
7,912
+175
| +2% | +$134 | ﹤0.01% | 5523 |
|
|
2024
Q4 | $9.87K | Buy |
7,737
+1,684
| +28% | +$2.15K | ﹤0.01% | 5440 |
|
|
2024
Q3 | $12.5K | Buy |
6,053
+261
| +5% | +$540 | ﹤0.01% | 5333 |
|
|
2024
Q2 | $22.1K | Buy |
5,792
+518
| +10% | +$1.97K | ﹤0.01% | 5183 |
|
|
2024
Q1 | $25K | Buy |
5,274
+675
| +15% | +$3.2K | ﹤0.01% | 5127 |
|
|
2023
Q4 | $19.6K | Buy |
4,599
+963
| +26% | +$4.11K | ﹤0.01% | 5207 |
|
|
2023
Q3 | $11.2K | Sell |
3,636
-584
| -14% | -$1.81K | ﹤0.01% | 5407 |
|
|
2023
Q2 | $19K | Buy |
4,220
+4,042
| +2,271% | +$18.2K | ﹤0.01% | 5455 |
|
|
2023
Q1 | $1.02K | Sell |
178
-164
| -48% | -$935 | ﹤0.01% | 6050 |
|
|
2022
Q4 | $2.07K | Sell |
342
-29
| -8% | -$175 | ﹤0.01% | 5681 |
|
|
2022
Q3 | $2K | Buy |
371
+184
| +98% | +$992 | ﹤0.01% | 5847 |
|
|
2022
Q2 | $1K | Buy |
187
+87
| +87% | +$465 | ﹤0.01% | 6278 |
|
|
2022
Q1 | $1K | Sell |
100
-3,052
| -97% | -$30.5K | ﹤0.01% | 6488 |
|
|
2021
Q4 | $39K | Buy |
3,152
+3,109
| +7,230% | +$38.5K | ﹤0.01% | 5608 |
|
|
2021
Q3 | $2K | Hold |
43
| – | – | ﹤0.01% | 6253 |
|
|
2021
Q2 | $1K | Sell |
43
-972
| -96% | -$22.6K | ﹤0.01% | 6371 |
|
|
2021
Q1 | $44K | Sell |
1,015
-3,791
| -79% | -$164K | ﹤0.01% | 5521 |
|
|
2020
Q4 | $344K | Buy |
+4,806
| New | +$344K | ﹤0.01% | 4689 |
|